We are live on ! Find out more

Clarivate

CLVT

Market cap $1.16B

1.82 USD

-0.05

2.67%

At close Updated Oct 27, 4:00 PM EDT

Pre-market

After hours

1.82

0.00

0%

1 day

-2.67%

5 days

2.82%

1 month

6.43%

3 months

-14.55%

6 months

-26.02%

Year to date

-43.83%

1 year

-50.81%

5 years

-91.79%

10 years

-81.04%

About: Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.

Employees: 12,000

Technology Information Technology Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 18.8%

Neutral 81.3%

Negative 0%

Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence

More than 100 institutions across 25 countries and regions are using the AI-native research intelligence platform. LONDON, Oct. 22, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that more than 100 institutions across 25 countries and regions have adopted Web of Science Research Intelligence, highlighting growing global customer demand since the platform launched in May 2026.

Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

WASHINGTON--(BUSINESS WIRE)--Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, to develop AI-enhanced patent workflow solutions. This partnership brings together Sterne Kessler's practitioner-built technology and deep patent practice expertise with Clarivate's leading IP data and software. Together, the.

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the successful completion of the sale of its Life Sciences & Healthcare segment to Altaris, LLC ("Altaris"), advancing Clarivate's transformation and simplifying its portfolio. The transaction for $600 million was previously announced on July 6, 2026.

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "Notes") for aggregate principal amount of up to $75,000,000 (the "Maximum Amount"), upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase") and any related documents (collectively with the Offer to Purchase, the "Tender Offer Documents").

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase").

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026 before the market opens on Tuesday, November 3, 2026.

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), has commenced a cash tender offer (the "Offer") to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase").

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2026, a distinguished group of 22 researchers whose work is of Nobel class.

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Accuserve Solutions (“Accuserve” or the “Company”), an independent managed repair services platform connecting insurance carriers, homeowners, and contractors, today announced the appointment of Maroun S.

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LONDON, Aug. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the expansion of agentic AI capabilities across the Cortellis portfolio, helping life sciences R&D teams accelerate discovery, strengthen safety assessment and make faster, more informed portfolio decisions. By embedding AI directly within existing workflows, the new capabilities enable researchers to reduce manual effort, navigate complexity and focus on higher-value scientific and strategic decisions.

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

See News Rankings

Price charts implemented using Lightweight Charts™